Spironolactone for Reducing Proteinuria in Diabetic Nephropathy

NCT00498537 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

FED

Sponsor class

Conditions

Diabetic Nephropathy

Interventions

DRUG: spironolactone

Sponsor

US Department of Veterans Affairs